{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:52:46Z","timestamp":1767966766864,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/nrurol.2016.165","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T10:50:36Z","timestamp":1472727036000},"page":"570-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Low adherence to guidelines in non-muscle-invasive disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Bas W. G.","family":"van Rhijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"BFnrurol2016165_CR1","doi-asserted-by":"publisher","unstructured":"Chang, S. S.  et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J. Urol. \n                    http:\/\/dx.doi.org\/10.1016\/j.juro.2016.06.049\n                    \n                   (2016).","DOI":"10.1016\/j.juro.2016.06.049"},{"key":"BFnrurol2016165_CR2","doi-asserted-by":"publisher","unstructured":"Babjuk, M.  et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. \n                    http:\/\/dx.doi.org\/10.1016\/j.eururo.2016.05.041\n                    \n                   (2016).","DOI":"10.1016\/j.eururo.2016.05.041"},{"key":"BFnrurol2016165_CR3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/bju.12012","volume":"112","author":"JA Witjes","year":"2013","unstructured":"Witjes, J. A.  et al. Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Gu\u00e9rin (BCG): results of an international individual patient data survey (IPDS). BJU Int. 112, 742\u2013750 (2013).","journal-title":"BJU Int."},{"key":"BFnrurol2016165_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000321926","volume":"86","author":"P Gontero","year":"2011","unstructured":"Gontero, P.  et al. Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. Urol. Int. 86, 19\u201324 (2011).","journal-title":"Urol. Int."},{"key":"BFnrurol2016165_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00120-013-3134-4","volume":"52","author":"C Reek","year":"2013","unstructured":"Reek, C.  et al. Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany. Urologe A 52, 986\u2013990 (2013).","journal-title":"Urologe A"},{"key":"BFnrurol2016165_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1445-2197.2011.05894.x","volume":"81","author":"MT Siddins","year":"2011","unstructured":"Siddins, M. T., Wong, V. V., Fitzgerald, J. T. & Bamberg, L. J. Challenges in non-muscle invasive bladder cancer: lessons from a regional review. ANZ J. Surg. 81, 889\u2013894 (2011).","journal-title":"ANZ J. Surg."},{"key":"BFnrurol2016165_CR7","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1002\/cncr.24311","volume":"115","author":"R Madeb","year":"2009","unstructured":"Madeb, R.  et al. Treatment of non-muscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer 115, 2660\u20132670 (2009).","journal-title":"Cancer"},{"key":"BFnrurol2016165_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5489\/cuaj.3143","volume":"10","author":"GT Gotto","year":"2016","unstructured":"Gotto, G. T., Shea-Budgell, M. A. & Dean Ruether, J. Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta. Can. Urol. Assoc. J. 10, 33\u201338 (2016).","journal-title":"Can. Urol. Assoc. J."},{"key":"BFnrurol2016165_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2008.04.016","volume":"180","author":"GJ Huang","year":"2008","unstructured":"Huang, G. J., Hamilton, A. S., Lo, M., Stein, J. P. & Penson, D. F. Predictors of intravesical therapy for non-muscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project. J. Urol. 180, 520\u2013524 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol2016165_CR10","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1002\/cncr.26198","volume":"117","author":"K Chamie","year":"2011","unstructured":"Chamie, K.  et al. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer 117, 5392\u20135401 (2011).","journal-title":"Cancer"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2016.165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2016.165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2016.165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:15:34Z","timestamp":1684469734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2016.165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnrurol2016165"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2016.165","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]},"assertion":[{"value":"31 August 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}